Skip to main content
Log in

Neue europäische Leitlinien für die Herzschrittmacher- und die kardiale Resynchronisationstherapie

Was hat sich geändert?

New ESC guidelines on cardiac pacing and cardiac resynchronization therapy

What has changed?

  • Schwerpunkt
  • Published:
Herz Aims and scope Submit manuscript

Zusammenfassung

Im Juni 2013 wurden die neuen Leitlinien zur Herzschrittmacher- und Resynchronisationtherapie der European Society of Cardiology (ESC) veröffentlicht. Gegenüber den letzten Leitlinien aus dem Jahr 2007 kam es zu einigen fundamentalen Änderungen. Vor allem wurden die Leitlinien näher am klinischen Bild orientiert. Es wurde besonders Wert auf eine einfache Umsetzbarkeit gelegt. Die neuen Leitlinien richten sich damit nicht nur an Elektrophysiologen, sondern an Kardiologen, Internisten und Allgemeinmediziner.

Abstract

The latest guidelines of the European Society of Cardiology (ESC) on cardiac pacing and cardiac resynchronization therapy were presented and published in June 2013. Compared to the last guidelines from 2007 several substantial changes have been made. The new guidelines are much more clinically oriented with a special focus on practicability. The intention is a better usefulness not only for electrophysiologists but also for cardiologists, internists and general practitioners.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6
Abb. 7
Abb. 8
Abb. 9
Abb. 10
Abb. 11
Abb. 12

Literatur

  1. Vardas PE, Auricchio A, Blanc JJ et al (2007) Guidelines for cardiac pacing and cardiac resynchronisation therapy. The Task Force for Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology. Developed in collaboration with the European Heart Rhythm Association. Eur Heart J 28:2256–2295

    Article  PubMed  Google Scholar 

  2. Brignole M, Auricchio A, Baron-Esquivias G et al (2013) 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34:2281–2329

    Article  PubMed  Google Scholar 

  3. Brignole M, Menozzi C, Moya A et al (2012) Pacemaker therapy in patients with neurally mediated syncope and documented asystole: Third International Study on Syncope of Uncertain Etiology (ISSUE-3): a randomized trial. Circulation 125:2566–2571

    Article  PubMed  Google Scholar 

  4. Nielsen JC, Thomsen PE, Højberg S et al (2011) A comparison of single-lead atrial pacing with dual-chamber pacing in sick sinus syndrome. Eur Heart J 32:686–696

    Article  PubMed  Google Scholar 

  5. Cleland JG, Swedberg K, Cohen-Solal A et al (2000) The Euro Heart Failure Survey of the EUROHEART survey programme. A survey on the quality of care among patients with heart failure in Europe. The Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The Medicines Evaluation Group Centre for Health Economics University of York. Eur J Heart Fail 2:123–132

    Article  CAS  PubMed  Google Scholar 

  6. Bristow MR, Saxon LA, Boehmer J et al (2004) Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350:2140–2150

    Article  CAS  PubMed  Google Scholar 

  7. Abraham WT, Fisher WG, Smith AL et al (2002) Cardiac resynchronization in chronic heart failure. N Engl J Med 346:1845–1853

    Article  PubMed  Google Scholar 

  8. Cleland JG, Daubert JC, Erdmann E et al (2005) The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 352:1539–1549

    Article  CAS  PubMed  Google Scholar 

  9. Chung ES, Leon AR, Tavazzi L et al (2008) Results of the Predictors of Response to CRT (PROSPECT) Trial. Circulation 117:2608–2616

    Article  PubMed  Google Scholar 

  10. Linde C, Abraham WT, Gold MR et al (2008) Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 52:1834–1843

    Article  PubMed  Google Scholar 

  11. Moss AJ, Hall WJ, Cannom DS et al (2009) Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 361:1329–1338

    Article  PubMed  Google Scholar 

  12. Tang AS, Wells GA, Talajic M et al (2010) Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 363:2385–2395

    Article  CAS  PubMed  Google Scholar 

  13. Curtis AB, Worley SJ, Adamson PB et al (2013) Biventricular pacing for atrioventricular block and systolic dysfunction. N Engl J Med 368:1585–1593

    Article  CAS  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. K.-H. Kuck weist auf folgende Beziehungen hin: St. Jude Medical GmbH, Medtronic, Abbott Vascular. T. Tönnis gibt an, dass kein Interessenkonflikt besteht.

Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Tönnis.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kuck, KH., Tönnis, T. Neue europäische Leitlinien für die Herzschrittmacher- und die kardiale Resynchronisationstherapie. Herz 39, 941–951 (2014). https://doi.org/10.1007/s00059-014-4179-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00059-014-4179-x

Schlüsselwörter

Keywords

Navigation